Cobalt(III) Schiff Base Complexes as Irreversible Inhibitors of the Metallo-β-Lactamase NDM-1
ACS Infectious Diseases · 03.11.2026
DOI: 10.1021/acsinfecdis.6c00433 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 03.11.2026. Verfasst von Hendryck A Gellineau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Northwestern University, 2530 Campus Dr.Evanston, Illinois60208, United States. Hauptthemen laut MEDLINE: Cobalt, beta-Lactamases, beta-Lactamase Inhibitors, Anti-Bacterial Agents. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Burroughs Wellcome Fund, Achievement Rewards for College Scientists Foundation, Trinity College of Arts and Sciences, Duke University.
Abstract (Originalsprache)
Antibiotic resistance is a critical public health concern, with approximately 2.8 million Americans infected with antibiotic-resistant bacteria annually and over 35,000 deaths in the United States alone. Of particular concern are Enterobacterales that express metallo-β-lactamases (MBLs), bacteria that cause nosocomial infections and exhibit resistance to most β-lactam drugs. The zinc-containing active sites of MBLs differ from those of serine β-lactamases, making current clinical inhibitors ineffective. No FDA-approved MBL inhibitors exist, leaving a critical gap in therapeutics for MBL-expressing Enterobacterales infections. Herein, we biochemically and spectroscopically demonstrate irreversible inhibition of the metallo-β-lactamase NDM-1 by a subset of cobalt(III) Schiff base complexes (Co(III)-sb). Crystallography and 59Co NMR experiments show that inactivation efficiency is dependent on axial and equatorial ligand identity. While Co(III)-sb exhibits NDM-1 inhibition, chemical modification is required to enable complexes to cross the Gram-negative envelope. These findings establish Co(III)-sb complexes as a novel scaffold for the development of MBL inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Northwestern University, 2530 Campus Dr.Evanston, Illinois60208, United States.
- Department of Chemistry, Duke University, 124 Science Drive, Durham, North Carolina27708, United States.
ORCID-Profile: Addison M Duda, Zachary J Mast, Sarah S Angle, Lin X Chen, Katherine J Franz, Thomas J Meade
Förderung
- Burroughs Wellcome Fund
- Achievement Rewards for College Scientists Foundation
- Trinity College of Arts and Sciences, Duke University
- International Institute for Nanotechnology, Northwestern University
- Joe Taylor Adams Fellowship from Duke University
- Marcil-Monahan Scholar of Trinity College of Arts and Sciences, Duke University
Zitieren
APA
Gellineau, H. A., Duda, A. M., Mast, Z. J., Angle, S. S., Ladhani, A. D., Chen, L. X., Franz, K. J., & Meade, T. J. (2026). Cobalt(III) Schiff Base Complexes as Irreversible Inhibitors of the Metallo-β-Lactamase NDM-1. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00433
Vancouver
Gellineau HA, Duda AM, Mast ZJ, Angle SS, Ladhani AD, Chen LX, et al. Cobalt(III) Schiff Base Complexes as Irreversible Inhibitors of the Metallo-β-Lactamase NDM-1. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00433
BibTeX
@article{Gellineau2026,
author = {Gellineau, Hendryck A and Duda, Addison M and Mast, Zachary J and Angle, Sarah S and Ladhani, Andrew D and Chen, Lin X and Franz, Katherine J and Meade, Thomas J},
title = {Cobalt(III) Schiff Base Complexes as Irreversible Inhibitors of the Metallo-β-Lactamase NDM-1},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.6c00433}
}
EUVIMED